Cellectar Biosciences Inc Strategic Asset Allocation Index
Cellectar Biosciences Inc strategic asset allocation index. Cellectar Biosciences Inc (CLRB) has a Strategic Asset Allocation Index of 10.3% as of December 2022. Strategic assets (PP&E of $978.98K plus long-term investments of $-) total $978.98K, measured against net assets of $9.54 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Cellectar Biosciences Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Cellectar Biosciences Inc (2010–2022)
Strategic asset allocation index of Cellectar Biosciences Inc from 2010 to 2022. This chart shows how Cellectar Biosciences Inc's Strategic Asset Allocation Index has evolved across 13 annual periods from 2010 to 2022. As of December 2022, the index stands at 10.3%, representing strategic assets of $978.98K against net assets of $9.54 Million USD. Check Cellectar Biosciences Inc (CLRB) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Cellectar Biosciences Inc Strategic Asset Allocation Index by Year (2010–2022)
Cellectar Biosciences Inc strategic asset allocation index by year from 2010 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Cellectar Biosciences Inc from 2010 to 2022, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Cellectar Biosciences Inc market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 10.3% | $978.98K | $978.98K | $- | $9.54 Million | ▲ +8.6 pp |
| 2021 | 1.7% | $549.13K | $549.13K | $- | $33.05 Million | ▲ +0.9 pp |
| 2020 | 0.8% | $430.98K | $355.98K | $75.00K | $54.79 Million | ▼ -4.8 pp |
| 2019 | 5.6% | $510.08K | $435.08K | $75.00K | $9.06 Million | ▼ -2.5 pp |
| 2018 | 8.2% | $1.08 Million | $543.34K | $540.82K | $13.26 Million | ▲ +5.9 pp |
| 2017 | 2.3% | $244.71K | $244.71K | $- | $10.75 Million | ▼ -8.4 pp |
| 2016 | 10.7% | $1.44 Million | $1.44 Million | $- | $13.54 Million | ▼ -94.1 pp |
| 2015 | 104.8% | $1.73 Million | $1.73 Million | $- | $1.65 Million | ▲ +85.8 pp |
| 2014 | 18.9% | $2.03 Million | $2.03 Million | $- | $10.75 Million | ▼ -120.0 pp |
| 2013 | 138.9% | $2.36 Million | $2.36 Million | $- | $1.70 Million | ▲ +112.8 pp |
| 2012 | 26.0% | $2.65 Million | $2.65 Million | $- | $10.16 Million | ▼ -6.1 pp |
| 2011 | 32.1% | $3.04 Million | $3.04 Million | $- | $9.48 Million | ▼ -258.8 pp |
| 2010 | 290.9% | $3.51 Million | $3.51 Million | $- | $1.21 Million | — |